This is the authors' abstract. We don't add key points for this paper.
The disorders classified as non-Hodgkin's lymphoma are increasing in frequency in the United States, with more than 35,000 cases diagnosed annually. In recent years, there have been numerous advances in our understanding of the biology of these disorders and in their treatment. In this article, these advances will be reviewed in the same order as a physician should consider them when seeing a new patient with non-Hodgkin's lymphoma: the diagnosis is considered first, followed by the prognosis, choice of treatment, and treatment itself.Clinically Important Subtypes of Non-Hodgkin's LymphomaUnlike the related disorder Hodgkin's disease, non-Hodgkin's lymphoma has a firmly . . .
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Wood et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: